Clinical decision support
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
It can also predict the onset of Parkinson's motor symptoms.
Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization.
In a panel discussion, IT professionals and health system executives discussed the challenges of implementing AI across diverse healthcare settings.
In a panel discussion, experts emphasized that AI must align with clinical workflows, reduce cognitive load, and support – not replace – clinicians.
MAI-DxO AI reportedly diagnosed complex medical cases with over four times higher accuracy than generalist physicians and saved costs.
Also, a Taiwanese startup has received the US FDA's 510(k) clearance for its neurosurgical robot.
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
Selected early versions will be slated for real-world deployment.